Revenio Group Corporation: Revenio Group Corporation's Capital markets Day on August 28, 2013
Revenio Group Corporation Stock Exchange Release August 28, 2013 at 10:00 a.m.
Revenio Group Corporation's Capital markets Day on August 28, 2013 Revenio Group Corporation is organizing a Capital Markets Day for analysts, portfolio managers and media representatives on August the 28th, 2013 starting at 11:30 a.m. in Helsinki. The day's presentations will concentrate on Revenio's and especially on its subsidiary Icare Finland Oy's updated strategy and growth drivers. The speakers of the event are Olli-Pekka Salovaara, President and CEO of Revenio; Timo Hilden, CEO of Icare Finland Oy; John Floyd, CEO of Icare USA and Pekka Raatikainen, CFO of Revenio. Revenio is a Finnish health tech group whose core business is Icare's tonometers. Tonometers are used to identify and screen for Glaucoma, that is, chronic elevated pressure within the eye. Revenio strives for growth in health technology, both organically and inorganically. In addition to organic growth, Revenio seeks opportunities to supplement its current product portfolio with innovative health tech products with growth potential that would complement Icare's existing global distribution network. The objective is to utilize Icare's existing distribution network with a more comprehensive product portfolio for wider customer base. According to Revenio's view, the major growth drivers for Icare Finland Oy's business operations are aging population and population growth, the global cost pressure in the health care, the increasing awareness of Glaucoma and the growth of patient driven eye pressure screenings. Revenio Group Corporation's financial guidance remains unchanged. In continuing operations, consolidated net sales and operating profit excluding non-recurring items are expected to see year-on-year growth. The Capital Markets Day's presentation is available on Revenio's website www.revenio.fi at 12:00 p.m. on August the 28(th), 2013, onwards. Revenio Group Corporation Olli-Pekka Salovaara CEO and President For additional information: Pekka Raatikainen, CFO Tel. +358 50 553 4094 E-mail: pekka.raatikainen@revenio.fi DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Principal media www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group's success. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. The Revenio Group also includes other business operations, which are grouped under the Technology and Services segment. This segment's operations have a shared global market and represent the cutting edge of technology products and services in their industry. These businesses are extremely profitable in their industries and generate positive cash flow. In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its operating margin standing at 19.4 percent. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki.